Here’s what you should know:
1. The Pure-Vu system cleanses the colon intraprocedurally, allowing for improved visualization during colonoscopies. Motus is first launching in the U.S. market and will target Japan in the future.
2. Motus is completing several post-approval clinical trials and pilot commercial evaluations in the U.S.
3. Motus plans to launch the Pure-Vu system commercially in the U.S. in 2019.
4. Motus GI CEO Mark Pomeranz said, “The need to improve the quality, efficiency and cost-effectiveness of inpatient colonoscopy procedures is a global issue. While our immediate focus continues to be on market development and preparation for commercial launch of the Pure-Vu System for inpatient colonoscopy in the U.S., we believe Japan is a key international market for future commercial expansion.”
More articles on gastroenterology:
HCA revenues grow 7.4% & more — 7 ASC company key notes
Key trends and concepts for a thriving ASC: 3 questions with Polaris Spine COO Joy Taylor
2 big trends for ASCs from North Texas Team Care Surgery Center’s Adam Hornback
